CP
CP
NYSE · Road & Rail

Canadian Pacific Kansas City

$93.50
-0.42 (-0.45%)
As of Aug 15, 1:02 AM ET ·
CP News16 articles
Coeur Mining tumbles 9% as Canadian guidance cut overshadows record cash flow
Coeur Mining (CDE) shares slid 8.8% after cutting Canadian output guidance, overshadowing record quarterly cash flow and higher gold production.
Markets
Ford Stock Slips After Canadian Labor Deal Secures Truck Production
Ford shares dipped 1.5% to $14.02 after a Canadian labor agreement was ratified, safeguarding truck production while limiting cost increases.
Markets
Ford Rises 4.8% as Canadian Labor Deal Eases Risk, F-150 Supply Focus
Ford's shares climbed 4.8% last week as a tentative labor agreement with Unifor reduced Canadian risk, while investors eye F-150 supply improvements and Q2 results.
Markets
WELL Health Rises After Acquiring Canadian Clinics at Attractive Multiple
WELL Health Technologies shares rose 3.1% after buying two Canadian clinics at a price lower than its own public valuation.
Markets
Canadian Natural Resources Trails TSX as Buyback Efficiency Improves
Canadian Natural Resources (CNQ) gained 0.8% to C$56.67, underperforming the TSX, as its discounted share price boosts buyback efficiency.
Markets
Ford Shares Flat as Canadian Labor Talks Begin; Inventory Poses Pricing Risk
Ford shares hover around $14 as Unifor begins Canadian labor negotiations, while elevated F-Series inventory raises potential pricing concerns.
Markets
Ford Shares Slip as Canadian Labor Talks Loom
Ford shares dropped 5.3% in a holiday-shortened week, underperforming the S&P 500, as investors brace for Unifor labor talks in Toronto that may shape Detroit Three bargaining.
Markets
Robinhood Clears Canadian Regulatory Hurdle, Eyes Growth Amid Crypto Revenue Dip
Robinhood Markets has secured regulatory approval to enter Canada through its acquisition of Coinsquare Capital Markets, with closing expected around June 1. The move comes as the company faces a 47% drop in crypto revenue.
Crypto
Canadian Stocks Hit New High as Tech and Mining Rally Offsets Energy Slide
The S&P/TSX Composite Index reached a new closing record of 34,830.89, up 1%, as tech and mining stocks advanced, while energy shares declined on a near 7% drop in Brent crude.
Markets
Shell's $16.4B ARC Buy Boosts Canadian LNG Ambitions
Shell's $16.4B acquisition of ARC Resources strengthens its position in Canada's Montney shale and LNG Canada terminal, boosting Asian export prospects.
Markets
Xero Data Reveals U.S. Small Business Sales Slowdown, Canadian Contraction
Xero's latest data shows U.S. small business sales growth decelerated sharply to 0.9% year-over-year in the December quarter, with Canadian sales contracting 4.1%. The company cited tariff impacts and policy uncertainty.
Economy
Denison Mines Secures Key Canadian Approval for Phoenix Uranium Mine
Denison Mines Corp. shares advanced in premarket trading following Canadian regulatory approval for construction of its flagship Phoenix uranium mine. The decision shifts focus to the company's final investment decision and construction timeline.
Commodities
Paladin Energy Gains on Key Canadian Uranium Project Approval
Paladin Energy Ltd. advanced after receiving provincial environmental sign-off for its Patterson Lake South uranium project in Canada. The approval marks a key regulatory milestone as the company progresses toward federal licensing.
Commodities
Air Transat Launches Direct Rio Flights Amid Canadian Airline Route Expansion
Air Transat initiates nonstop Toronto/Montreal-Rio de Janeiro service, becoming the sole carrier on the Montreal route. The move coincides with a broader February route rollout by Canadian and international airlines.
Markets
Novartis Advances with Canadian Reimbursement and Major U.S. R&D Expansion
Novartis shares gained as the company secured a draft reimbursement nod in Canada for Kisqali and broke ground on a $23 billion U.S. research center. Investors eye upcoming dividend and annual meeting.
Markets
Merck Shares Approach 52-Week High on Canadian RSV Drug Approval
Merck stock gained 1.8% after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140, while insider sales were disclosed.
Markets